Related by context. Frequent words. (Click for all words.) 52 #Q filing 51 Shareholder Letter 49 Mr. Fater 49 #QSB 48 8K filing 47 Form #QSB 47 theforward looking 47 www.amedisys.com 47 Form 8K 46 pro forma adjusted EBITDA 46 Redishred 46 Complete Response letter 46 TheCompany 45 interim unaudited consolidated 45 www.ahtreit.com 45 unaudited consolidated interim 45 www.cokecce.com 45 accompanying unaudited consolidated 45 www.syneron.com 45 Ian Foreman P.Geo 44 www.spec.org 44 http:/www.nabi.com 44 Investor Fact Sheet 44 PreGen Plus 44 NASDAQ BMTI 44 Filing Statement dated 44 www.PinkSheets.com 43 normalized FFO 43 www.nuinsco.ca 43 condensed consolidated balance sheets 43 PV module shipments 43 audited financials 43 Inc. NASDAQ MIPI 43 CFO Exercises Options 42 pro forma EBITDA 42 Updates Fourth Quarter 42 http:/www.accuridecorp.com 42 WpHG processed 42 www.microtune.com 42 www.akorn.com 42 NEO3 42 NASDAQ SLXP today 42 seasonally slowest 42 press release 42 risks anduncertainties 42 Q2 FY# [001] 41 Inc. NASDAQ EXEL 41 unaudited condensed consolidated 41 Inc. Nasdaq ACOR 41 Q1 FY# [001] 41 horizontal Marcellus Shale 41 www.evolving.com 41 forwardlooking statements 41 suchforward looking 41 Company Prospectus dated 41 www.ipsen.com 41 www.BMRN.com 40 www.conceptus.com 40 LSE YAU 40 QTinno 40 www.emisphere.com 40 PD2i Analyzer ™ 40 www.ventanagold.com 40 forward lookingstatements 40 base redetermination 40 Hycroft mine 40 differ materiallyfrom 40 http:/www.omtr.com 40 CHMP opinion 40 http:/phx.corporate-ir.net/playerlink.zhtml?c=#REWE Group 40 results 40 reaudit 40 condensed consolidated financial 40 www.marketaxess.com 40 DISCLOSURE NOTICE 39 Preliminary Assessment Study 39 through GroupWeb EmailWire.Com 39 seasonally weakest 39 ONEOK Partners segment 39 GeoBio 39 auditor attestation 39 Statements Certain 39 exhibits thereto 39 widens Quick Facts 39 differmaterially 39 Statements Statements 39 HERmark 39 Management Proxy Circular 39 restated financials 39 attached hereto 39 www.teck.com 39 Corporation NASDAQ DENN 39 * Potentially libelous 39 Q4 FY# [001] 39 NYSE Euronext PHARM 39 CEO Exercises Options 39 un audited 39 Hycroft Mine 39 tables summarize 39 updated NI #-# 39 earns rev